[go: up one dir, main page]

AU2001290309A1 - Method of diagnosing nephropathy - Google Patents

Method of diagnosing nephropathy

Info

Publication number
AU2001290309A1
AU2001290309A1 AU2001290309A AU9030901A AU2001290309A1 AU 2001290309 A1 AU2001290309 A1 AU 2001290309A1 AU 2001290309 A AU2001290309 A AU 2001290309A AU 9030901 A AU9030901 A AU 9030901A AU 2001290309 A1 AU2001290309 A1 AU 2001290309A1
Authority
AU
Australia
Prior art keywords
diagnosing nephropathy
nephropathy
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290309A
Inventor
Masanori Hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex International Reagents Co Ltd
Original Assignee
International Reagents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Reagents Corp filed Critical International Reagents Corp
Publication of AU2001290309A1 publication Critical patent/AU2001290309A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001290309A 2000-10-27 2001-09-28 Method of diagnosing nephropathy Abandoned AU2001290309A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000329102 2000-10-27
JP2000-329102 2000-10-27
PCT/JP2001/008512 WO2002037099A1 (en) 2000-10-27 2001-09-28 Method of diagnosing nephropathy

Publications (1)

Publication Number Publication Date
AU2001290309A1 true AU2001290309A1 (en) 2002-05-15

Family

ID=18805840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290309A Abandoned AU2001290309A1 (en) 2000-10-27 2001-09-28 Method of diagnosing nephropathy

Country Status (5)

Country Link
US (1) US6969591B2 (en)
EP (1) EP1336845B1 (en)
JP (1) JPWO2002037099A1 (en)
AU (1) AU2001290309A1 (en)
WO (1) WO2002037099A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100488281B1 (en) 2001-09-15 2005-05-10 아람 바이오시스템 주식회사 Method and apparatus for amplification of nucleic acid sequences by using thermal convection
TWI233872B (en) * 2004-07-15 2005-06-11 New Sun Far East Corp Ltd Hand tool having warning function
EP2535718B1 (en) * 2007-05-11 2014-07-09 The Institutes for Pharmaceutical Discovery, LLC Methods for early diagnosis of kidney disease
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
US20090068683A1 (en) * 2007-06-11 2009-03-12 Mayo Foundation For Medical Education And Research Markers for preeclampsia
JP5515740B2 (en) * 2007-09-27 2014-06-11 国立大学法人 新潟大学 A urine pretreatment agent for urine protein quantification, a urine pretreatment method, and a urine protein quantification method.
JP5735411B2 (en) * 2009-02-23 2015-06-17 プリマハム株式会社 Allergen detection method by immunochromatography
US20120164667A1 (en) * 2009-06-10 2012-06-28 Masanori Hara Method for test on diabetic nephropathy
ES2530054T3 (en) * 2009-06-10 2015-02-26 Niigata University Test method in kidney diseases
AU2010339723B2 (en) 2009-12-21 2014-11-06 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-VEGF treatment
WO2011086497A2 (en) 2010-01-12 2011-07-21 Ahram Biosystems, Inc. Three-stage thermal convection apparatus and uses thereof
BR112012017152A2 (en) 2010-01-12 2020-10-06 Ahram Biosystems, Inc. two stage thermal convection apparatus and uses of it.
JPWO2011105474A1 (en) 2010-02-26 2013-06-20 原　正則 Test method for acute kidney injury
CN103189749A (en) * 2010-04-12 2013-07-03 新加坡国立大学 A biomarker for renal function in patients with type 2 diabetes
JP5866291B2 (en) 2010-09-30 2016-02-17 積水メディカル株式会社 Immunochromatographic test strip and method for producing the same
EP2702998A1 (en) 2012-08-31 2014-03-05 IMBA-Institut für Molekulare Biotechnologie GmbH Therapeutic and diagnostic miRNA regulator in kidney disease
JP6091158B2 (en) * 2012-10-23 2017-03-08 デンカ生研株式会社 Method to increase sensitivity of immunoassay system by pretreatment of urine with denaturant
EP2940471B1 (en) * 2012-12-26 2019-09-18 Hara, Masanori Method for detecting podocytes in urine
US9903795B2 (en) * 2012-12-28 2018-02-27 Beckman Coulter, Inc. Composition for high stringency cell treatment and antigen retrieval
JP6207002B2 (en) 2013-02-19 2017-10-04 国立大学法人 筑波大学 Method for estimating glomerular filtration rate from urinary megalin measurements
EP3189164B1 (en) 2014-09-05 2021-11-10 American University Of Beirut Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna
WO2016147514A1 (en) * 2015-03-17 2016-09-22 国立研究開発法人産業技術総合研究所 Method and kit for detecting stem cell
JP6751080B2 (en) * 2015-04-22 2020-09-02 原　正則 Method to estimate urinary podocyte count
WO2018177949A1 (en) * 2017-03-25 2018-10-04 Charité-Universitätsmedizin Berlin Urine flow cytometry as biomarker of renal diseases
CA3130051A1 (en) * 2019-02-18 2020-08-27 Nb Health Laboratory Co., Ltd. Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent
JP6714256B1 (en) 2019-12-18 2020-06-24 株式会社イムノセンス Electrochemical lateral flow immunoassay method, sensor thereof and method of manufacturing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (en) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flat diagnostic agent
DE69221666T2 (en) * 1991-05-24 1998-01-15 Wakamoto Pharma Co Ltd Method of diagnosing kidney disease by detecting albumin fragments
JP2932837B2 (en) * 1992-06-25 1999-08-09 富士レビオ株式会社 Method for measuring human podocalyxin
US5534431A (en) * 1994-02-28 1996-07-09 The Board Of Regents Of The University Of Nebraska Hybridomas and monoclonal antibodies specific for unique determinants of nephropathy-related immunoglobulin G and complexes thereof
US5707818A (en) * 1994-12-13 1998-01-13 Bsi Corporation Device and method for simultaneously performing multiple competitive immunoassays
WO1997008549A1 (en) * 1995-08-31 1997-03-06 Seikagaku Corporation Method for detecting kidney diseases, diagnostic drug therefor, and diagnostic kit therefor
US6673629B2 (en) * 1998-01-15 2004-01-06 Abbott Laboratories Neutralization of polycations in a chromatographic device for whole blood use
AU2477199A (en) * 1998-02-11 1999-08-30 Regents Of The University Of California, The Podocalyxin like sialomucins having selectin ligand activity
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
AU4169600A (en) * 1999-03-02 2000-09-21 Biostratum, Inc. Method for the detection of congenital nephrotic syndrome

Also Published As

Publication number Publication date
JPWO2002037099A1 (en) 2004-03-11
EP1336845A4 (en) 2006-06-07
EP1336845B1 (en) 2013-03-27
US20040058395A1 (en) 2004-03-25
EP1336845A1 (en) 2003-08-20
US6969591B2 (en) 2005-11-29
WO2002037099A1 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
AU2001290309A1 (en) Method of diagnosing nephropathy
AU2001263887A1 (en) Monitoring method
AU2001276484A1 (en) Drilling method
AU2001268138A1 (en) Method of performing distributed load testing
AU2002220579A1 (en) Method of evaluating formation properties
AU2002222172A1 (en) Method of retrieving entities
AU2001238696A1 (en) Method of reducing defects
AU2001276957A1 (en) Method of diagnosing pulmonary hypertension
AU2001294258A1 (en) Method of purifying plavastatin
AUPQ667800A0 (en) Detection method
AUPR050700A0 (en) Detection method
AU2001246964A1 (en) Method of manufacturing hydrogen
AU2001284578A1 (en) Toilet block
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001290313A1 (en) Service providing method
AU2001271032A1 (en) Means of examining nephropathy
AU2002309621A1 (en) Predictive method
AU2001241636A1 (en) Halotherapy method
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2002222927A1 (en) Method of making hydrofluorocarbons
AU2001271220A1 (en) Body-cavity probe and method
AU2001290731A1 (en) Structural prediction of allosterism
GB0024938D0 (en) Method of diagnosis
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002228975A1 (en) Method